Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin

[1]  P. Tsai,et al.  Phosphoinositide 3-kinase β, phosphoinositide 3-kinase δ, and phosphoinositide 3-kinase γ mediate the anti-inflammatory effects of magnesium sulfate. , 2015, The Journal of surgical research.

[2]  P. Tsai,et al.  Vasopressin inhibits endotoxin binding in activated macrophages. , 2015, The Journal of surgical research.

[3]  D. Strassheim,et al.  Targeted Inhibition of Heat Shock Protein 90 Suppresses Tumor Necrosis Factor–&agr; and Ameliorates Murine Intestinal Inflammation , 2014, Inflammatory bowel diseases.

[4]  Chun-Jen Huang,et al.  Vasopressin inhibits endotoxin-induced upregulation of inflammatory mediators in activated macrophages , 2013 .

[5]  K. Okkenhaug.  Signaling by the phosphoinositide 3-kinase family in immune cells. , 2013, Annual review of immunology.

[6]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[7]  Chie-Pein Chen,et al.  Antiinflammation Effect of Human Placental Multipotent Mesenchymal Stromal Cells Is Mediated by Prostaglandin E2 via a Myeloid Differentiation Primary Response Gene 88-dependent Pathway , 2012, Anesthesiology.

[8]  W. Fung-Leung.  Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function. , 2011, Cellular signalling.

[9]  P. Shepherd,et al.  Both p110α and p110β Isoforms of Phosphatidylinositol 3‐OH‐Kinase are Required for Insulin Signalling in the Hypothalamus , 2010, Journal of neuroendocrinology.

[10]  K. Walley,et al.  Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R. , 2008, Resuscitation.

[11]  D. Payen,et al.  Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits , 2008, Intensive Care Medicine.

[12]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[13]  M. Zvelebil,et al.  Exploring the specificity of the PI3K family inhibitor LY294002. , 2007, The Biochemical journal.

[14]  Lin-Cheng Yang,et al.  Heme Oxygenase 1, Nuclear Factor E2–related Factor 2, and Nuclear Factor &kgr;B Are Involved in Hemin Inhibition of Type 2 Cationic Amino Acid Transporter Expression and l-Arginine Transport in Stimulated Macrophages , 2006, Anesthesiology.

[15]  C. Rommel,et al.  Signaling through PI3Kγ: a common platform for leukocyte, platelet and cardiovascular stress sensing , 2005, Thrombosis and Haemostasis.

[16]  C. Chong,et al.  Low plasma vasopressin/norepinephrine ratio predicts septic shock. , 2005, The American journal of emergency medicine.

[17]  D. Payen,et al.  Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits* , 2004, Critical care medicine.

[18]  J. Granton,et al.  Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology , 2003, Critical care.

[19]  D. Annane,et al.  Circulating vasopressin levels in septic shock. , 2003, Critical care medicine.

[20]  E. Corsini,et al.  The anti‐inflammatory activity of estrogen in glial cells is regulated by the PKC‐anchoring protein RACK‐1 , 2002, Journal of neurochemistry.

[21]  N. Mackman,et al.  The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells* , 2002, The Journal of Biological Chemistry.

[22]  H. Bruining,et al.  Vasopressin deficiency contributes to the vasodilation of septic shock. , 1998, Circulation.

[23]  M. Oz,et al.  Vasopressin pressor hypersensitivity in vasodilatory septic shock. , 1997, Critical care medicine.

[24]  C. H. Baker,et al.  Microvascular vasopressin effects during endotoxin shock in the rat. , 1990, Circulatory shock.

[25]  J. Hamerton,et al.  Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor , 1985, Somatic cell and molecular genetics.

[26]  R. Schrier,et al.  Central nervous system mediators of vasopressin release. , 1983, Physiological reviews.

[27]  M. Recanatini,et al.  Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[28]  B. Payrastre,et al.  Regulation and roles of PI3Kβ, a major actor in platelet signaling and functions. , 2011, Advances in enzyme regulation.